CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

November 18, 2023

Primary Completion Date

August 26, 2025

Study Completion Date

November 14, 2025

Conditions
Stroke, Acute IschemicStroke, Acute
Interventions
DRUG

Intraarterial alteplase

See arm/group descriptions.

Trial Locations (14)

Unknown

Hospital Universitario de A Coruña, A Coruña

Hospital Universitario Dr. Balmis, Alicante

Hospital Germans Trías i Pujol, Badalona

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital Universitario de Cruces, Bilbao

Hospital Josep Trueta, Girona

Hospital Universitario Virgen de la Arrixaca, Murcia

Hospital Universitario Central de Asturias, Oviedo

Hospital Universitario Son Espases, Palma de Mallorca

Hospital Universitario de Navarra, Pamplona

Hospital Universitario de Donostia, San Sebastián

Hospital Univesitario y Politénico La Fe, Valencia

Hospital Universitario de Valladolid, Valladolid

08014

Hospital Clinic Barcelona, Barcelona

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER

NCT05797792 - CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2). | Biotech Hunter | Biotech Hunter